Promising new research into medical uses of cannabis has shown that marijuana may hold the key to treating Alzheimer’s disease. But the governments mishmosh of laws make it illegal to move forward with clinical lab tests on mice and, if the results are promising, move on to human trials.
Marijuana is still listed as a Schedule I controlled substance under the Controlled Substances Act (CSA) of 1970. A substance is placed in Schedule I if it is determined to have no currently accepted medical use, a lack of accepted safety for use under medical supervision and a high potential for abuse. Other Schedule I classified drugs include heroin and LSD. The irony is that the government also holds Patent No. 6,630,507 covering the potential use of non-psychoactive cannabinoids for medical purpose.
In order to acquire marijuana for further studies, labs must first apply to the Drug Enforcement Agency. It’s not uncommon for years to pass before any decision is made on whether to allow labs to continue research programs.
“It’s so blatantly obvious that this plant should be studied in greater detail, and yet we have this major roadblock stopping it.” -Dr. David Schubert, professor at the Salk Institute for Biological Studies
With a huge baby boomer population approaching old age, time is of the essence and we can’t continue to wait for politicians to argue about their personal opinions on legal marijuana. It’s time to remove cannabis from the Schedule 1, and allow the scientific community wide and free access to study cannabinoids.